Curve’s innovative mammalian cell drug discovery platform to enable identification and optimisation of novel small molecule drug candidates against MSD targets Potentially game-changing platform enables direct discovery of functionally active molecules against difficult to drug targets expressed in their native intracellular environment Southampton, UK, 16th February 2022: Curve Therapeutics (Curve), a private biotechnology company pioneering […]
This author has not written his bio yet.
But we are proud to say that oncotron contributed 2 entries already.
Entries by oncotron
Curve Therapeutics is seeking to appoint a Head of Drug Discovery to lead its innovative small molecule therapeutic programmes from functional hit to development candidate. Curve is an ambitious, VC-backed drug discovery company that is applying its powerful cell-based functional screening platform to address challenging disease-modifying targets. The company’s vision is to use this platform to develop a pipeline of first-in-class small molecule drugs for the treatment of cancer.